NC, M., CA, P., J, D., 3rd, W. E., & JS, L. (2017). Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury. Stem cells translational medicine, 6(10), 1917. https://doi.org/10.1002/sctm.17-0065
Chicago Style (17th ed.) CitationNC, Manley, Priest CA, Denham J, Wirth ED 3rd, and Lebkowski JS. "Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury." Stem Cells Translational Medicine 6, no. 10 (2017): 1917. https://doi.org/10.1002/sctm.17-0065.
MLA (9th ed.) CitationNC, Manley, et al. "Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury." Stem Cells Translational Medicine, vol. 6, no. 10, 2017, p. 1917, https://doi.org/10.1002/sctm.17-0065.